Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study

Autor: Boukovinas, I., Souglakos, J., Hatzidaki, D., Kakolyris, S., Ziras, N., Vamvakas, L., Polyzos, A., Geroyianni, A., Agelidou, A., Agelaki, S., Kalbakis, K., Kotsakis, A., Mavroudis, D., Georgoulias, V.
Zdroj: In Lung Cancer 2009 63(1):77-82
Databáze: ScienceDirect